University of Stirling breakthroughs parasite research

Alexander Dindial, lead researcher on the study <i>(Image: University of Stirling)</i>
Alexander Dindial, lead researcher on the study (Image: University of Stirling)
This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The Herald.

New Stirling research is shedding light on how to combat parasites.

A team from the University of Stirling has made a breakthrough in understanding how to control salmon lice, a major parasite affecting farmed salmon and costing the global aquaculture industry more than £1 billion each year.

Their study focused on the secretions produced by salmon lice at the larval stage and identified significant differences from those in adult lice.

These findings could play a key role in developing new, more effective ways to tackle infestations early.

Salmon lice are a major problem for aquaculture, feeding on the skin, mucus, and blood of the host fish.

This can lead to open wounds, increased risk of infection, reduced market value, and greater susceptibility to disease.

Alexander Dindial, lead researcher on the study, said: "Because this is the very first stage of this parasite’s life cycle, it represents a vital linchpin in control strategies for this species.

"This work better helps us understand salmon louse biology and could play a vital role in informing future research into control of this parasite, such as through the identification of vaccine targets, which ultimately promote the sustainable production of healthy salmon and enhance global food security."

Treatments for sea lice are currently costly, environmentally damaging, and sometimes unreliable, raising concerns for both animal welfare.

The Stirling study revealed that larval salmon lice, known as copepodids, produce 143 unique secretory proteins not found in adults.

Many of these proteins, including serpins and other molecules, resemble those in land-based parasites like mosquitoes and ticks and are believed to suppress the host's immune response.

The research was led by the University of Stirling’s Institute of Aquaculture, with support from the Moredun Research Institute and funding from EastBio.

To identify the secretory proteins, the team incubated samples of larval lice in either filtered seawater or a solution containing isophorone, a compound naturally present in Atlantic salmon mucus that acts as an attractant for copepodids.

They then used liquid chromatography tandem mass spectrometry to analyse the protein make-up of the secretions, filtering the data to determine which proteins were secretory and comparing the results between samples.

The proteins identified could become the basis for new vaccine development.

Dr Sean Monaghan, co-supervisor of the study, said: "This data provides key candidates for vaccines in the future.

"We are currently exploring the genes of these secreted proteins as part of a large BBSRC funded project, GeNoLice, to determine if they are influenced by interactions with the host."

The study, titled Investigation of proteins identified in the secretory and excretory products (SEPs) of the infectious copepodid stage of the salmon louse Lepeophtheirus salmonis, has been published in the journal Veterinary Parasitology.

Get involved
with the news

Send your news & photos